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Abstract A cDNA encoding achacin, an antimicrobial glyco-
protein from the body surface mucus of giant African snail
Achacina fulica FeŁrussac, was expressed in a methylotrophic
yeast, Pichia pastoris, and recombinant achacin (rAch) was
secreted in yeast minimal medium in a polyglycosylated form
with 80 kDa. Carbohydrate analysis revealed that the glyco-
sylated moiety of rAch was composed of 50 mol mannose and
2 mol N-acetylglucosamine residues. Antimicrobial activity using
Escherichia coli and Staphylococcus aureus showed that the rAch
had a behavior similar to its native counterpart. The rAch showed
so wide an antimicrobial spectrum that 0.1 mg/ml rAch inhibited
the growth of Pseudomonas fluorescens, Staphylococcus epider-
midis, and Streptococcus faecalis in addition to E. coli and
S. aureus, whereas it did not appreciably affect the growth of
Proteus mirabilis, Bacillus cereus and Micrococcus luteus. The
rAch was also effective in preventing growth of Vibrio
anguillarum and Vibrio parahaemolyticus. The results suggested
that the rAch had great potential of using as an antimicrobial
agent.
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1. Introduction
Recently food poisoning has frequently erupted throughout
the year resulting in serious consequences. The production of
antimicrobial agents with a wide antimicrobial spectrum
should be valuable for food safety. However, the use of anti-
biotics to control the bacterial infection has been a concern
because it may incite a generation of drug-resistant bacteria
strains. Therefore, safe antimicrobial agents which are harm-
less to humans have been sought in the natural environment.
The macromolecular antibacterial glycoprotein from edible
snail could be useful as a harmless food additive to prevent
bacterial growth. Unlike vertebrates, it is assumed that the
snail has a special defense mechanism against bacterial infec-
tion. An antibacterial factor named achacin that acts on both
Gram-negative and Gram-positive bacteria was found in the
body surface mucus of the giant African snail, Achacina fulica
FeŁrussac [1]. Achacin has been characterized as a glycopro-
tein, which shows a bactericidal e¡ect against Escherichia coli
and Staphylococcus aureus [1^3]. Recently, a cDNA encoding
achacin precursor was cloned from the tissue of the snail
collar [4], and four tentative N-glycosylation sites, Asn-Xaa-
Ser/Thr, were discovered based on the deduced amino acid
sequence [4]. Morphological studies revealed that achacin at-
tacked the cytoplasmic membranes of bacteria and then killed
the bacteria [5]. Our previous study suggested that recombi-
nant unglycosylated achacin produced by E. coli expression
system did not exhibit any antimicrobial activity (data not
shown). Thus, the N-glycosylation moiety of achacin might
be highly related to the antibacterial activity. A lower eukary-
ote, e.g. yeast, may be suitable for the production of a bio-
logically active achacin with carbohydrate chains. We were
successful in obtaining active proteins with polymannosyl
chains using two yeast expression systems [6,7]. The chain
length of mannosyl groups of protein derived from a methyl-
otrophic yeast Pichia pastoris was shorter and more homoge-
neous than that from Saccharomyces cerevisiae [7]. Therefore,
we expressed the achacin gene in P. pastoris The objective of
this study was to produce a bioactive achacin by genetic en-
gineering.
2. Materials and methods
2.1. Materials
P. pastoris KM71 (Invitrogen, San Diego, CA) was used as a host
in this study. E. coli JM 109 (recA endA1 gyrA96 thi hsdR17 supE44
relA1 D (lac-proAB) mcrA FP traD36 proA proB lacIq lacZDM15)
was used for routine plasmid ampli¢cation. T4 DNA ligase, alkaline
phosphatase and restriction enzymes were purchased from Promega
(Madison, WI). Q-Sepharose Fast Flow, Superdex 200HR, and con-
canavalin A-Sepharose were from Pharmacia (Baie d’UrfeŁ, Que., Can-
ada). All other chemicals were of analytical grade for biochemical use.
2.2. Construction of expression plasmid, transformation, and culture
condition
The construction of P. pastoris expression vector was performed
based on the method described in the manual of the Pichia expression
kit (Invitrogen). To express mature achacin with a native N-terminus,
the signal sequence with the kex2 cleavage (E-K-R) was introduced at
the upstream of the N-terminal amino acid (E) of achacin by PCR
using 5P-AGG CTC GAG AAA AGA GAA GCT CCC CAG TGC-
3P as a primer. Plasmid pDR-A2 carrying the complementary DNA of
achacin [4] was used as a template for the PCR procedure. A 1.6 kbp
achacin cDNA with the signal sequence was ligated into the P. pas-
toris expression vector pPICZK-A. The resulting vector was linearized
with a restriction enzyme DraI, and the linearized DNA was intro-
duced into P. pastoris cells according to the EasyComp transforma-
tion protocol in the manual. Integration of achacin in the recombi-
nant genomes of P. pastoris was con¢rmed by genomic PCR using
5PAOX1 primer paired with 3PAOX1 primer, 5P-GAC TGG TTC
CAA TTG ACA AGC-3P and 5P-GCA AAT GGC ATT CTG ACA
TCC-3P. Transformants were grown in 5 ml of the yeast minimal
medium (YMM) containing 0.4 mg/l biotin at 30‡C for 24 h, then
subcultured in fresh one liter YMM containing 0.5% methanol as the
sole carbon source.
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2.3. Puri¢cation
Culture of the recombinant yeast was centrifuged at 10 000Ug for
10 min, and the supernatant was concentrated using an ultra¢lter
system with 3000 mol wt cut-o¡ (Pellicon cassette ¢lter, PLBC 000
05, Millipore, Bedford, MA). The concentrated culture was applied to
a Q-Sepharose Fast Flow column (1.3U10 cm) pre-equilibrated with
20 mM Tris-HCl bu¡er (pH 7.5). The column was washed with the
same bu¡er until a protein-free fraction was obtained, and then the
protein was eluted with a linear gradient to 500 mM NaCl in the
bu¡er. Fractions including achacin were combined after Western blot-
ting as described later. The combined fractions were then concen-
trated by pressure ultra¢ltration using a Dia£o YM30 membrane
(Amicon, Danvers, MA). The sample was applied to a Pharmacia
FPLC Superdex 200HR column (1.0U30 cm) pre-equilibrated with
20 mM Tris-HCl bu¡er (pH 7.5). Protein content in each fraction
eluted was determined by measuring absorbance at 280 nm. Carbohy-
drate content was measured from absorbance at 490 nm after color
development using the phenol-sulfuric acid reaction [8]. All fractions
containing glycoproteins were combined and applied to a concanava-
lin A-Sepharose column (1.3U5 cm) previously washed with 10 bed
volumes of 20 mM Tris-HCl bu¡er (pH 7.5) containing 500 mM
NaCl, followed by washing again with the same bu¡er until the
washed solution became protein free. The adsorbed glycoprotein
was then eluted with 100 mM methyl K-D-mannopyranoside in the
20 mM Tris-HCl bu¡er (pH 7.5) containing 500 mM NaCl, and
served for further experiments after dialysis against deionized water.
2.4. SDS-polyacrylamide gel electrophoresis and Western blot analysis
SDS-polyacrylamide gel electrophoresis was carried out according
to the method of Laemmli [9] using 10% acrylamide separating gel
and 3% stacking gel containing 1% SDS. Samples were heated at
100‡C for 5 min in Tris-glycine bu¡er (pH 8.8) containing 1% SDS
and 1% L-mercaptoethanol. Electrophoresis was run at a constant
current of 10 mA for 5 h in an electrophoretic bu¡er of Tris-glycine
containing 0.1% SDS. The gel sheets, thereafter, were stained with
0.025% Coomassie brilliant blue R-250. For Western blot analysis,
the gel sheet was transferred to a PVDF membrane after electropho-
resis as described [10,11]. The membrane was incubated for 30 min at
room temperature in 10 mM Tris-HCl bu¡er (pH 8.0) containing 5%
skim milk, 150 mM NaCl and 0.05% Tween 20. Then the membrane
was incubated with the rabbit antiserum raised against the wild-type
achacin [4] for 60 min at room temperature. Finally, the antigen,
reacted with goat anti-rabbit IgG conjugated with alkaline phospha-
tase on the membrane, was detected by the enzyme-linked coloration
reaction [12,13].
2.5. Carbohydrate analysis
The total sugar content of the glycosylated achacin was estimated
using the phenol-sulfuric acid reaction employing mannose as a stand-
ard. HPLC analysis was used for identifying the hexose liberated from
the glycoprotein by hydrolysis with 2 N HCl at 100‡C for 3 h in a
sealed glass ampoule. The hydrolysates were dried, dissolved in water,
and chromatographed on an Asahipak NH2P-50 column (Asahi
Chemical, Tokyo) in 75% acetonitrile using a Hitachi HPLC system
equipped with an RI detector.
2.6. Antimicrobial assays
The test bacteria used in this study were eight Gram-negative bac-
teria namely E. coli ATCC 25922, Proteus mirabilis IFO 13300, Pseu-
domonas £uorescens IFO 14160, Aeromonas hydrophila subsp. hydro-
phila IFO 13286, A. hydrophila KAH 8501, Aeromonas salmonicida
IFO 12718, Vibrio anguillarum IFO 13266 and Vibrio parahaemolyti-
cus IFO 12711. As Gram-positive bacteria, Staphylococcus aureus
ATCC 25923, S. epidermidis IFO 13889, Bacillus cereus IFO 13690,
Streptococcus faecalis IFO 12970 and Micrococcus luteus IFO 13867
were also used.
Antibacterial activity of achacin was estimated from the growth
curve of E. coli and S. aureus. These strains were subcultured and
then grown in L-broth (10 g of bacto tryptone, 5 g of bacto yeast
extract, 5 g of NaCl, 1 g of glucose, and water to 1 liter) at 37‡C
overnight. The fresh cells were diluted with L-broth and microscopi-
cally adjusted to give a concentration of 103 cells/ml by using a hem-
atometer. A 100 Wl aliquot of the cell suspension was then added to
the tested sample with and without achacin in 5 ml saline solution.
After vortexing, the inoculated samples were incubated at 37‡C while
rotating at 250 rpm. Bacterial number was counted on MacConkey
agar (Difco, Detroit, MI) plate for E. coli and Mannitol salt agar
(Difco) plate for S. aureus.
The antimicrobial spectrum was assessed using a stainless-steel
cylinder cup with 8.0 mm outside diameter, 6.0 mm inside diameter
10 mm high. Overnight culture of the test bacteria was spread onto a
Standard agar (Difco) plate, which was left for 1 h in a germ-free
cabinet to dry the surface of the agar plate. For V. parahaemolyticus,
the assay was carried out in 2.5% NaCl of the ¢nal concentration.
10 Wl of the achacin solution was injected into the stainless-steel cup
on the agar plate, and incubated for 24 h at 37‡C. The diameter of an
antibacterial zone which formed surrounding the stainless-steel cup
was measured using slide calipers.
3. Results and discussion
3.1. Expression of achacin in P. pastoris
Mature achacin was successfully secreted from the trans-
formants in a form of a molecular mass of 80 kDa, as shown
in Fig. 1. Western blot analysis revealed that the single band
in Fig. 1 cross-reacted with rabbit antiserum raised against the
wild-type achacin (data not shown), thereby suggesting it to
be the recombinant achacin (rAch). The rAch was analyzed
for the amino acid sequence from the N-terminus using an
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Table 1
Antimicrobial activity of the recombinant achacin
Bacterial strains Recombinant achacin
1 mg/ml 0.1 mg/ml
Gram-negative bacteria
Escherichia coli ATCC 25922 +++ +++
Proteus mirabilis IFO 13300 + þ
Pseudomonas £uoresces IFO 14160 +++ +++
Aeromonas hydrophila subsp. hydrophila IFO 13286 ++ +
Aeromonas hydrophila KAH 8501 ++ +
Aeromonas salmonicida IFO 12718 ++ +
Vibrio anguillarum IFO 13266 +++ +
Vibrio parahaemolyticus IFO 12711 ++ +
Gram-positive bacteria
Staphylococcus aureus ATCC 25923 +++ +++
Staphylococcus epidermidis IFO 13889 +++ +++
Bacillus cereus IFO 13690 + þ
Streptococcus faecalis IFO 12970 +++ +++
Micrococcus luteus IFO 13867 + þ
+++, over 12 mm in diameter (strong antimicrobial activity); ++, 12^10 mm (moderate activity); +, 10^8 mm (weak activity); þ , 8 mm (not
detected). The data are the averages of triplicate determinations.
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Applied Biosystems 476A sequencer (Foster City, CA). The
N-terminal sequence was NH2-EAPQCSRSVDVA, which was
identical to that of authentic achacin [4] except for the second
amino acid of A as was to be expected. The second amino
acid G of authentic achacin was substituted to the amino acid
A in order to increase an e⁄ciency of recognition by signal
peptidases. This result indicates that the mature protein (502
amino acids and 55.8 kDa molecular mass [4]) is correctly
processed during the expression in the host cells. The yield
of the rAch was calculated as 0.2 mg/l. The carbohydrate
liberated from the rAch was identi¢ed as hexose. The
HPLC analysis revealed that the glycosylation moiety of the
rAch is composed of mannose and N-acetylglucosamine. The
carbohydrate composition ratio was determined by employing
mannose and N-acetylglucosamine as a standard. 50 mol of
mannose and 2 mol of N-acetylglucosamine appeared to link
per mol achacin according to the weight ratio. These results
indicate that the rAch carries Man50GlcNAc2-linked form.
3.2. Antimicrobial activity of the recombinant achacin
The antimicrobial activity of achacin was determined using
a typical Gram-negative bacterium E. coli and Gram-positive
bacterium S. aureus. Fig. 2 illustrates the destruction of E. coli
by 12 Wg/ml of wild-type achacin (wAch) isolated from snail
mucus after 3 h incubation at 37‡C. At concentrations lower
than 1.2 Wg/ml, there was a dose-dependent delay in the onset
of detectable growth. On the other hand, S. aureus was more
sensitive against wAch as described earlier [3], the growth was
totally inhibited at achacin concentrations in excess of 1.2 Wg/
ml. At lower concentrations, the onset of exponential growth
curve was retarded. For both bacteria tested, the concentra-
tion of achacin below that necessary for total inhibition re-
sulted in a marked delay in reaching adequate viable colony-
forming units. The rAch showed a bacteriostatic e¡ect similar
to the wAch at low concentrations. The rAch prevented the
growth of E. coli and S. aureus resulting in no increase in
bacterial number for 9 h and 12 h, respectively (Fig. 2). The
antibacterial activity of rAch at a concentration of 8.5 Wg/ml
was equivalent to that of wAch at 0.12 Wg/ml (1/70 activity),
for both E. coli and S. aureus. The carbohydrate moiety of the
wAch was shown to contain not only mannose but also sialic
acids, glucose, fucose and xylose [14], which may play an
important role of the biological activity of the novel antimi-
crobial glycoprotein. Achacin makes up a relatively new class
of antimicrobial agents which possess a unique mechanism,
unlike vancomycin and relevant glycopeptide antibiotics,
which exert their antimicrobial e¡ect by binding to carboxy-
terminal peptide targets in the bacterial cell wall preventing
the biosynthesis of peptidoglycan [15]. It is worth noting that
the antibacterial activity of the rAch is e¡ective in the richer
media, in which the same phenomenon was observed on the
wAch in the heart infusion bouillon medium [3].
The rAch showed a broad antimicrobial spectrum (Table 1).
1 mg/ml rAch showed an antibacterial activity against all
tested bacteria of eight Gram-negative and ¢ve Gram-positive
bacteria. The growth of E. coli, P. £uorescens, S. aureus, S.
epidermidis, and S. faecalis was strongly suppressed even at
the achacin concentration of 0.1 mg/ml. The rAch was e¡ec-
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Fig. 2. Growth curve of E. coli and S. aureus with and without
achacin in L-broth. Data are from a representative experiment re-
peated ¢ve times with similar results. a, Control (without achacin);
W, 8.5 Wg/ml recombinant achacin, b, 0.12 Wg/ml native achacin;
O, 1.2 Wg/ml native achacin; P, 12 Wg/ml native achacin. ND, not
detected.
Fig. 1. SDS-polyacrylamide gel electrophoresis of the recombinant
achacin secreted from P. pastoris. a: MW marker (94 kDa, phos-
phorylase; 67 kDa, bovine serum albumin; 43 kDa, ovalbumin; 30
kDa, carbonic anhydrase); b: recombinant achacin.
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tive on V. anguillarum and V. parahaemolyticus, as well. On
the other hand, the rAch did not appreciably a¡ect the growth
of P. mirabilis, B. cereus and M. luteus.
The achacin produced by E. coli expression system did not
show antimicrobial activity. The present study suggested that
the carbohydrate moiety could play an important role in ex-
hibiting the biological activity of the protein, despite the fact
that the role of the carbohydrate moiety recognized in the
rAch from P. pastoris is unclear. Although it has been shown
that the yeast expression system can be used to increase the
stability to heating or proteolysis due to protein glycosylation,
an excessive polymannosyl chain may not be suitable for pro-
ducing active protein [6]. The hyperglycosylated lysozyme ex-
pressed in Saccharomyces cerevisiae decreased the lytic activity
to only 11% when the insoluble cell wall of Micrococcus lyso-
deikticus was used as substrate [6]. Polyglycosylation in the
rAch may bring about the antimicrobial activity lower than
that of the wAch. It may be caused by a reduction of the
harmful e¡ects of achacin on yeast growth. Compared to a
number of reports documenting high-level expression of for-
eign genes in P. pastoris [16], the amount of the rAch secreted
in YMM in this study was quite low (0.2 mg/l). Achacin may
be harmful for the growth of host yeast.
The present study reports that biologically active achacin
with polymannosyl chains has been successfully produced us-
ing the Pichia expression system The e¡ects of extracellular
pH and incubation temperature during cultivation on the gly-
cosylation patterns of heterologous proteins in yeast await for
further study.
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